Startup Atlas · Chronic Disease Management
Wellthy Therapeutics Acquired
Abhishek Shah · Co-Founder & CEO
Prayat Shah · Co-Founder & VP, Enterprise Partnerships
Maaz Shaikh · Co-Founder
Mayuresh Joshi · Co-Founder
$7.6 MnTotal funding (tracked)
4Funding rounds
15 Jun 2023Last round
Wellthy Therapeutics: Funding Rounds
Disclosed round amounts over time, USD millions.
| Date | Round | Amount | Investors | Source |
|---|---|---|---|---|
| 15 Jun 2023 | Undisclosed | Undisclosed | Beyond Next Ventures | source |
| 13 Apr 2020 | Pre-Series A | $4 Mn (Rs 30 Cr) for 16% stake | Saama Capital | source |
| 19 Feb 2019 | Corporate Round | Rs 10.5 Cr ($1.5 Mn) for 11.71% stake | Cipla | source |
| 5 Mar 2018 | Seed | Rs 13.5 Cr ($2.1 Mn) | Beenext Ventures Currae Healthtech Fund GrowX Ventures IIFL Select Equity Fund Manipal Education & Medical Group | source |
Wellthy Therapeutics: Investors
Beyond Next Ventures Saama Capital Cipla Beenext Ventures Currae Healthtech Fund GrowX Ventures IIFL Select Equity Fund Manipal Education & Medical Group
Acquisitions
| Date | Acquirer | Acquired | Amount | Source |
|---|---|---|---|---|
| 13 Feb 2024 | TruDoc | Wellthy Therapeutics | Undisclosed | source |
FAQs on Wellthy Therapeutics
How much funding has Wellthy Therapeutics raised?
Wellthy Therapeutics has raised $7.6 Mn across 4 tracked funding round(s), most recently on 2023-06-15. Figures are compiled from cited public sources.
Who are the investors in Wellthy Therapeutics?
Investors in Wellthy Therapeutics include Beyond Next Ventures, Saama Capital, Cipla.
Sources & corrections.
Every fact on this page is compiled from cited public sources — follow the “source” links beside each entry. Profile sources: www.prnewswire.com entrackr.com · Last verified 18 Jul 2026. · Report a correction